Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexis Vallée
Observed name:
A Vallée
Institutions:
Centre Hospitalier Universitaire Sainte-Justine,
CHU Sainte-Justine Research Center,
Université de Montréal
Observed institutions:
Centre Hospitalier Universitaire Sainte-Justine,
CHU Sainte-Justine Research Center,
Université de Montréal
ORCID:
0009-0008-7761-5368
Observed ORCID:
0009-0008-7761-5368
OpenAlex ID:
A5011957269
Combined IFN-γ and JAK inhibition to treat hemophagocytic lymphohistiocytosis in mice
2022
·
Josée-Anne Joly
, Alexis Vallée
, et al.
·
Journal of Allergy and Clinical Immunology
·
28
Inhibition of IL2Rß-dependent STAT5 activity supports T-cell stemness and augments antitumor efficacy of CD8 + T cells by preventing T-cell exhaustion
2025
·
M Shourian
, B Bourdin
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Evaluation of T-Cell Compartment By Complex Multiparameter Flow Cytometry Reveals Distinct Patterns of T-Cell Exhaustion in DLBCL, FL and HL Patients
2019
·
Alexis Vallée
, Mitra Shourian
, et al.
·
Blood
·
1
Table S5 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Figure S2 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Data from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Figure S1 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Table S4 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Table S1 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Figure S3 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Table S3 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
Table S2 from In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy
2026
·
Mitra Shourian
, Benoîte Bourdin
, et al.
·
Cancer Immunology Research
Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab
2021
·
Victoria Korsos
, Alexis Vallée
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Lack of stem-like exhausted T cells and increased inhibitory receptor expression distinguishes diffuse large B cell lymphomas from Hodgkin lymphoma
2021
·
Alexis Vallée
, Mitra Shourian
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
15
Citation count:
30
H-index:
1
I10-index:
1
Year
Topic
Type